Masayoshi Shichiri

12.5k total citations · 1 hit paper
230 papers, 10.1k citations indexed

About

Masayoshi Shichiri is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Masayoshi Shichiri has authored 230 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Endocrinology, Diabetes and Metabolism, 67 papers in Molecular Biology and 65 papers in Surgery. Recurrent topics in Masayoshi Shichiri's work include Nitric Oxide and Endothelin Effects (36 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (34 papers) and Hormonal Regulation and Hypertension (28 papers). Masayoshi Shichiri is often cited by papers focused on Nitric Oxide and Endothelin Effects (36 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (34 papers) and Hormonal Regulation and Hypertension (28 papers). Masayoshi Shichiri collaborates with scholars based in Japan, United States and Brazil. Masayoshi Shichiri's co-authors include Yukio Hirata, Fumiaki Marumo, Toshiaki Emori, Hiroki Kishikawa, Y Ohkubo, Kazuki Ohta, Nakayasu Wake, Hiroki Kato, John M. Sedivy and Kazuo Kanno and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Masayoshi Shichiri

225 papers receiving 9.8k citations

Hit Papers

Long-term results of the Kumamoto Study on optimal diabet... 2000 2026 2008 2017 2000 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    2000 578 citations Masayoshi Shichiri, Hiroki Kishikawa et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayoshi Shichiri Japan 55 3.3k 2.7k 2.7k 2.7k 2.4k 230 10.1k
Eliot H. Ohlstein United States 58 3.5k 1.1× 3.4k 1.3× 2.2k 0.8× 1.3k 0.5× 3.9k 1.6× 198 10.8k
Mansoor Husain Canada 48 4.3k 1.3× 1.3k 0.5× 2.6k 1.0× 4.8k 1.8× 2.5k 1.0× 158 10.9k
Masakazu Kohno Japan 51 2.8k 0.8× 2.4k 0.9× 1.4k 0.5× 2.1k 0.8× 4.0k 1.7× 273 9.1k
Oscar A. Carretero United States 68 4.4k 1.3× 3.2k 1.2× 1.1k 0.4× 2.7k 1.0× 6.6k 2.8× 313 14.1k
Tsutomu Hirano Japan 47 2.0k 0.6× 1.9k 0.7× 3.0k 1.1× 3.8k 1.4× 1.9k 0.8× 252 9.0k
Matthew D. Breyer United States 70 6.6k 2.0× 2.6k 1.0× 1.6k 0.6× 2.8k 1.0× 1.9k 0.8× 204 16.0k
Janet J. Maguire United Kingdom 47 2.2k 0.7× 1.6k 0.6× 2.3k 0.8× 875 0.3× 1.6k 0.7× 136 7.1k
Daniel Henrion France 58 4.0k 1.2× 2.7k 1.0× 1.1k 0.4× 1.6k 0.6× 3.1k 1.3× 263 9.9k
Markus Hecker Germany 53 3.2k 1.0× 4.1k 1.5× 1.2k 0.5× 1.0k 0.4× 2.2k 0.9× 232 10.2k
Akira Sugawara Japan 56 4.7k 1.4× 1.2k 0.5× 1.2k 0.5× 1.8k 0.7× 2.6k 1.1× 294 10.4k

Countries citing papers authored by Masayoshi Shichiri

Since Specialization
Citations

This map shows the geographic impact of Masayoshi Shichiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayoshi Shichiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayoshi Shichiri more than expected).

Fields of papers citing papers by Masayoshi Shichiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayoshi Shichiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayoshi Shichiri. The network helps show where Masayoshi Shichiri may publish in the future.

Co-authorship network of co-authors of Masayoshi Shichiri

This figure shows the co-authorship network connecting the top 25 collaborators of Masayoshi Shichiri. A scholar is included among the top collaborators of Masayoshi Shichiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayoshi Shichiri. Masayoshi Shichiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fukuda, Izumi, et al.. (2025). Refractory Hypoglycemia Secondary to the Warburg Effect in Diffuse Large B-Cell Lymphoma. JCEM Case Reports. 3(4). luaf038–luaf038. 1 indexed citations
2.
Takano, Koji, Kazumi Fujimoto, Masaki Kobayashi, et al.. (2023). Robust increase in glucagon secretion after oral protein intake, but not after glucose or lipid intake in Japanese people without diabetes. Journal of Diabetes Investigation. 14(10). 1172–1174. 6 indexed citations
3.
Fujimoto, Kazumi, et al.. (2021). Circulating prorenin: its molecular forms and plasma concentrations. Hypertension Research. 44(6). 674–684. 4 indexed citations
4.
Kodera, Yoshio, et al.. (2020). Oxidised Met147 of human serum albumin is a biomarker of oxidative stress, reflecting glycaemic fluctuations and hypoglycaemia in diabetes. Scientific Reports. 10(1). 268–268. 22 indexed citations
5.
Okizaki, Shin-ichiro, Yoshiya Ito, Kanako Hosono, et al.. (2014). Suppressed recruitment of alternatively activated macrophages reduces TGF-β1 and impairs wound healing in streptozotocin-induced diabetic mice. Biomedicine & Pharmacotherapy. 70. 317–325. 113 indexed citations
6.
Oba, Kazuhito, Kanako Hosono, Hideki Amano, et al.. (2014). Downregulation of the proangiogenic prostaglandin E receptor EP3 and reduced angiogenesis in a mouse model of diabetes mellitus. Biomedicine & Pharmacotherapy. 68(8). 1125–1133. 15 indexed citations
7.
Hayashi, Akinori, et al.. (2013). The Time Interval from Meal to Peak Postprandial Glucose Levels Measured by Continuous Glucose Monitoring in Pregnant Women with Diabetes Mellitus. 56(9). 646–652. 2 indexed citations
8.
Watanabe, Takuya, Kengo Sato, Fumiko Itoh, et al.. (2013). Emerging Roles for Vasoactive Peptides in Diagnostic and Therapeutic Strategies Against Atherosclerotic Cardiovascular Diseases. Current Protein and Peptide Science. 14(6). 472–480. 16 indexed citations
9.
Fujimoto, Kazumi, Akinori Hayashi, Takuya Watanabe, et al.. (2013). Circulating Levels of Human salusin-β,a Potent Hemodynamic and Atherogenesis Regulator. PLoS ONE. 8(10). e76714–e76714. 37 indexed citations
10.
Shichiri, Masayoshi, Nozomi Fukai, Yutaka Kono, & Yujiro Tanaka. (2009). Rifampicin as an Oral Angiogenesis Inhibitor Targeting Hepatic Cancers. Cancer Research. 69(11). 4760–4768. 35 indexed citations
11.
Suzuki, Noriko, Masayoshi Shichiri, Takumi Akashi, et al.. (2007). Systemic Distribution of Salusin Expression in the Rat. Hypertension Research. 30(12). 1255–1262. 58 indexed citations
12.
Tateno, Toru, Hajime Izumiyama, Masaru Doi, et al.. (2007). Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. European Journal of Endocrinology. 157(6). 717–724. 75 indexed citations
13.
Shimizu, Koïchi, Masayoshi Shichiri, Peter Libby, Richard Lee, & Richard N. Mitchell. (2004). Th2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas. Journal of Clinical Investigation. 114(5). 739–739. 1 indexed citations
14.
Ishimaru, Shinya, Masayoshi Shichiri, Satoru Mineshita, & Yukio Hirata. (2001). Role of Endothelin-1/Endothelin Receptor System in Endotoxic Shock Rats.. Hypertension Research. 24(2). 119–126. 30 indexed citations
15.
Shichiri, Masayoshi, Hiroki Kato, Masaru Doi, Fumiaki Marumo, & Yukio Hirata. (1999). Induction of Max by Adrenomedullin and Calcitonin Gene-Related Peptide Antagonizes Endothelial Apoptosis. Molecular Endocrinology. 13(8). 1353–1363. 90 indexed citations
16.
17.
Kisanuki, Koichi, Hiroki Kishikawa, Eiichi Araki, et al.. (1995). Expression of insulin receptor on clonal pancreatic alpha cells and its possible role for insulin-stimulated negative regulation of glucagon secretion. Diabetologia. 38(4). 422–429. 42 indexed citations
18.
19.
Shichiri, Masayoshi, et al.. (1993). Effects of c-myc expression on proliferation, quiescence, and the G0 to G1 transition in nontransformed cells.. PubMed. 4(2). 93–104. 94 indexed citations
20.
Shichiri, Masayoshi, et al.. (1991). Effect of Low-Protein, Very-Low-Phosphorus Diet on Diabetic Renal Insufficiency With Proteinuria. American Journal of Kidney Diseases. 18(1). 26–32. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliot H. Ohlstein Breakdown of academic impact, for papers by Mansoor Husain Breakdown of academic impact, for papers by Masakazu Kohno Breakdown of academic impact, for papers by Oscar A. Carretero Breakdown of academic impact, for papers by Tsutomu Hirano Breakdown of academic impact, for papers by Matthew D. Breyer Breakdown of academic impact, for papers by Janet J. Maguire Breakdown of academic impact, for papers by Daniel Henrion Breakdown of academic impact, for papers by Markus Hecker Breakdown of academic impact, for papers by Akira Sugawara
Rankless by CCL
2026